E-cigarettes and Vaping-related Disease
Preventive medicine and care are crucial for combating various diseases, and this holds true for e-cigarette or vaping-related lung disease. Vaping has become a trendy and often praised alternative to traditional smoking. However, the safety of vaping was put into question when cases of e-cigarette or vaping-associated lung injury (EVALI) surfaced in 2019. E-cigarettes are battery-powered devices that heat a nicotine-containing liquid into a vapor that can be inhaled. Studies have shown that chemicals produced by e-cigarettes can cause lung inflammation, damage cells, and alter cell function in ways that promote the development of cancer. In addition, e-cigarettes can also cause chronic obstructive pulmonary disease (COPD), asthma, and other respiratory problems. Prevention of e-cigarette or vaping-related lung disease relies mainly on avoidance. The best way to prevent lung injury from e-cigarette use or vaping is to abstain from using these products. Children and teens must also avoid e-cigarettes and vaping products, as the use of these products among young people may pose a significant public health risk. The key to successful preventive medicine for e-cigarette or vaping-related lung disease is education. Health authorities, including healthcare professionals and educators, must spread knowledge about the potential dangers of e-cigarettes and vaping to the public, particularly to young people who are most susceptible to the risks of these products. In summary, preventive medicine and care is essential to prevent e-cigarette or vaping-related lung disease. Complete avoidance is the best strategy to avoid e-cigarette associated lung injury. Education plays a crucial role in providing knowledge about the risks of e-cigarettes and vaping to young people and the general public.
← Journal of Preventive Medicine And Care